Home Top Movers How Come The Aldeyra (ALDX) Stock Has Been Rising In Pre-Market Trades?

How Come The Aldeyra (ALDX) Stock Has Been Rising In Pre-Market Trades?

Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) rose 6.59% to trade at $12.78 per share at last check-in premarket trading. During Tuesday’s session, Aldeyra stock fell -4.00%, closing at $11.99. The daily volume of ALDX stock was 1.74 million shares, which was less than the 50-day average of 2.7 million shares. In the run-up to tomorrow’s quarterly results, ALDX stock has been going up.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

What is ALDX aiming at?

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

Aldeyra Therapeutics is a clinical-stage biotechnology company specializing in finding new ways to treat patients with immune-mediated diseases. RASP (reactive aldehyde species) are elevated in ocular and systemic inflammatory disease, and they are targets of ADX-629 and reproxalap, two of the ALDX’s lead investigational compounds. ALDX’s clinical pipeline also includes ADX-2191, an inhibitor of dihydrofolate reductase in Phase 3 trials for proliferative vitreoretinopathy.

Read More

On May 6, 2021 at 8:00 a.m. ET, Aldeyra will host a conference call to report financial results and discuss recent business highlights, announced ALDX in a press release today.

Also in last week, ALDX announced that its 0.25% recproxalap ophthalmic solution, an investigational new drug, has been found to be safe and effective for patients with allergic conjunctivitis in the Phase 3 INVIGORATE Clinical Trial.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

What ALDX is planning?

All secondary endpoints and the primary endpoint of the ALDX’s clinical trial were statistically significant. As part of its plans for the second half of 2021, Aldeyra (ALDX) will meet with the FDA to discuss the INVIGORATE results, along with the submission of a New Drug Application (NDA).

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Tyme Technologies, Inc. (TYME) Stock Trends downwards Following Strong Q4 2021 Financials and Progress in OASIS Trial

Tyme Technologies, Inc. (TYME) stock prices was down by -6.92% shortly after market trading commenced on June 11th, 2021, bringing the price per share...

Prophase Labs Inc. (PRPH) stock surged during pre-market trading session. Let’s figure out why?

Prophase Labs Inc. (NASDAQ: PRPH) stock soared by 5.87% at last close as well as the PRPH stock price has been observed rising by...

Why Surgalign Holdings, Inc. (SRGA) stock is gloomy today?

Surgalign Holdings, Inc. (SRGA) stock announced the $50 million registered direct offering priced at the market under Nasdaq rules today on June 10, 2021,...

Exela Technologies Inc. (XELA) stock soars during pre-market. Here’s what you should know?

Exela Technologies Inc. (NASDAQ: XELA) stock gained by 8.28% at last close while the XELA stock price rises in the pre-market as well, by...

Atossa Therapeutics, Inc. (ATOS) stock gains during pre-market trading. Here’s to know why?

Atossa Therapeutics, Inc. (NASDAQ: ATOS) stock declined by 27.51% at the last close while the ATOS stock price rises further by 9.09% in the...

Magnachip Semiconductor Corporation (MX) stock is Popping High today: Why is it so?

Shares of the Magnachip Semiconductor Corporation (MX) stock were popping high after the announcement of its receival of unsolicited buyout bid from Cornucopia Investment...

Why is Autolus Therapeutics plc (AUTL) stock rising today?

Shares of  Autolus Therapeutics plc (AUTL) stock were rising today on June 11, 2021, following the release of the presentation data related to obe-cel...

Mustang Bio, Inc. (MBIO) stock is climbing today: Here is to know why.

Mustang Bio, Inc. (MBIO) stock announced the updated interim data from Phase 1/2 clinical trial of its MB-106 CD20-targeted, autologous CAR T today on...

Related News

Magnachip Semiconductor Corporation (MX) stock is Popping High today: Why is it so?

Shares of the Magnachip Semiconductor Corporation (MX) stock were popping high after the announcement of its receival of unsolicited buyout bid from Cornucopia Investment...

Mustang Bio, Inc. (MBIO) stock is climbing today: Here is to know why.

Mustang Bio, Inc. (MBIO) stock announced the updated interim data from Phase 1/2 clinical trial of its MB-106 CD20-targeted, autologous CAR T today on...

Here’s why Soligenix, Inc. (SNGX) stock is Popping High today

Soligenix, Inc. (SNGX) stock gained Pediatric Investigation Plan (PIP) waiver for HyBryte™ (SGX301 or hypericin) by European Medicines Agency (EMA) after which the SNGX...

Clover Health Investments Corp. (CLOV) stock rises during pre-market. Let’s find out why?

Clover Health Investments Corp. (NASDAQ: CLOV) stock declined by 23.61% at last close while the CLOV stock price gains by 5.73% in the pre-market...

GameStop Inc. (GME) stock plunged during after-hour session. Here’s the update

GameStop Inc. (NASDAQ: GME) stock gained by 0.85% at the last close while the GME stock price declines by 5.21% in the after-hours session....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam